Expect continued, focused research from NASA and ESA into the underlying mechanisms of SANS. The development and testing of new diagnostic tools, potentially adapted from terrestrial medical devices, will likely accelerate. These tools aim to allow astronauts to perform self-administered eye exams and provide real-time data on ocular health during missions. Furthermore, researchers will be looking for effective physiological countermeasures, which could range from specific exercise regimens to pharmacological interventions, to prevent or reverse the effects of SANS before they impact mission performance.
Image: courtesy of Wired
The Race to Save Astronauts' Sight: Why Deep Space Missions Hinge on Beating SANS
Space agencies are grappling with a significant physiological challenge known as Spaceflight Associated Neuro-ocular Syndrome (SANS), which causes vision degradation in astronauts. With long-duration missions to the Moon and Mars on the horizon, NASA and the European Space Agency (ESA) are intensifying research into SANS, developing new monitoring devices and potential countermeasures. The ability to mitigate this condition is not just a matter of astronaut welfare; it is a critical operational hurdle that could determine the feasibility and safety of future human expeditions beyond low-Earth orbit.
Outlook
Background
Spaceflight Associated Neuro-ocular Syndrome, or SANS, is a condition observed in astronauts that results in changes to their vision and eye structure. It was formally named in 2017 to describe the vision degradation linked to space travel. The primary cause is understood to be the shift of fluids to the upper body in microgravity, which increases pressure in the skull and around the eyes. This elevated intracranial pressure can lead to symptoms like blurred vision and farsightedness.
Data collected by NASA indicates that SANS is a widespread concern. Approximately 29 percent of astronauts on short-duration space flights have reported a degradation in their distance or near-visual acuity. This figure jumps significantly for those on long-duration missions, with about 60 percent experiencing vision issues. These changes are not just subjective; the Ocular Health investigation, which collected data from International Space Station crew members between March 2013 and September 2016, found structural alterations to the eyes that appeared early in spaceflight and persisted throughout the mission. While some vision changes from SANS may linger after returning to Earth, no astronaut has yet reported permanent vision loss, according to Compton Eye Associates. Currently, astronauts sometimes use reading glasses with increased dioptre strength, informally known as 'space anticipation glasses,' to manage the visual acuity changes they experience.
Recent reports from May 22, 2026, also indicate concerns about the broader funding landscape for space science. While various announcements have been made, there has been a notable absence of new funding specifically for instrument development and science investigations. This could present a challenge to the pace of SANS research and the development of new solutions.
Precedents
The history of human spaceflight is a narrative of identifying physiological challenges and developing countermeasures. Early missions revealed issues with bone density loss and muscle atrophy due to microgravity. Agencies responded with rigorous exercise protocols, specialized equipment, and nutritional strategies. Similarly, radiation exposure has led to advanced shielding and mission planning to minimize astronaut risk. SANS represents the latest in this series of physiological hurdles that must be overcome for humans to safely extend their presence beyond Earth's immediate vicinity.
The Ocular Health investigation, conducted over several years, demonstrates a consistent pattern of space agencies systematically gathering data on astronaut health. This long-term monitoring and data collection are crucial for understanding the onset and progression of conditions like SANS. The approach mirrors how other space-related health issues have been studied and addressed: identify the problem, collect comprehensive data, research the mechanisms, and then develop solutions. The challenge with SANS is its relative novelty as a formally recognized syndrome and the complexity of its underlying cause, which involves fluid dynamics and neurological pressure within the confined environment of the human skull.
The stakes for resolving Spaceflight Associated Neuro-ocular Syndrome extend far beyond the comfort of individual astronauts. SANS poses a fundamental operational constraint on the ambitious deep-space missions that NASA and ESA are planning, particularly human expeditions to Mars. A significant percentage of astronauts experiencing vision degradation means that critical tasks, whether piloting a spacecraft through complex maneuvers, performing intricate repairs, or conducting scientific experiments on an alien surface, could be compromised. Clear vision is not merely an amenity; it is an absolute requirement for mission success and astronaut safety.
If SANS cannot be reliably prevented or reversed, it could force space agencies to impose strict limits on mission duration, restrict the pool of eligible astronauts, or even rethink the entire architecture of long-duration space exploration. The prospect of a human mission to Mars, which could last two to three years, becomes significantly more complex if crew members face progressive vision loss, making them less effective and potentially endangering the entire crew. The current reliance on 'space anticipation glasses' is a stop-gap measure, not a permanent solution, highlighting the urgent need for a deeper understanding and more robust interventions.
Furthermore, the lack of new funding for instrument development and science investigations, as noted on May 22, 2026, introduces a layer of institutional friction. While the problem is clearly identified and the need for solutions is pressing, the pace of progress could be influenced by resource allocation. Addressing SANS is therefore not just a scientific problem, but also a matter of strategic planning, resource commitment, and ultimately, the future trajectory of human space exploration itself.
Scenarios
AnalysisThe ongoing research into SANS could lead to several distinct outcomes, each with different implications for future space missions:
Outcome 1: Effective Countermeasures and Enhanced Mission Capability
Space agencies may successfully develop and implement a suite of effective countermeasures for SANS. This could involve a combination of new physiological protocols, such as specialized exercise regimens or dietary adjustments, alongside advanced pharmacological interventions. Crucially, it would also include the widespread adoption of sophisticated, self-administered ocular monitoring devices, potentially like those already used by octogenarians on Earth, ensuring real-time data on astronaut eye health. If these solutions prove robust, they would remove SANS as a significant barrier to long-duration missions, enabling crew members to maintain optimal visual acuity throughout extended journeys to the Moon, Mars, and beyond. This would allow for more complex scientific objectives and safer operations, accelerating the timeline for deep-space human exploration.
Outcome 2: Persistent Challenges and Operational Constraints
Despite dedicated research, SANS could prove more resistant to simple solutions than anticipated. The complex interplay of fluid shifts, intracranial pressure, and individual physiological responses might make a universal countermeasure difficult to develop. In this scenario, while some mitigation strategies might exist, vision degradation could remain a significant concern for long-duration missions. This would likely lead to stricter criteria for astronaut selection, potentially favoring individuals with particular physiological profiles, or imposing hard limits on mission durations. It could also necessitate more frequent crew rotations or more limited roles for astronauts experiencing significant SANS symptoms, introducing operational complexities and potentially slowing down ambitious deep-space exploration schedules.
Outcome 3: Technological Spinoffs and Broader Health Benefits
The intense focus on understanding and mitigating SANS could yield unexpected benefits beyond space travel. The research into fluid dynamics in the human body, intracranial pressure regulation, and remote ocular diagnostics could lead to significant advancements in terrestrial medicine. For example, insights gained from studying SANS might inform treatments for conditions like idiopathic intracranial hypertension (IIH) or glaucoma on Earth. The development of compact, portable, and user-friendly eye exam devices for space could also find widespread application in remote healthcare settings or for aging populations, offering a broader societal return on investment from space research.
Timeline
2013-03
Ocular Health Investigation Begins
NASA's Ocular Health investigation began gathering data from International Space Station crew members, monitoring structural alterations to their eyes during and after spaceflight.
2016-09
Ocular Health Investigation Concludes Data Collection
The Ocular Health investigation completed its data collection phase, providing critical insights into the physiological changes in astronauts' eyes during long-duration missions.
2017
SANS Officially Named
Scientists formally named the condition Spaceflight Associated Neuro-ocular Syndrome (SANS) to describe the vision degradation observed in astronauts during space missions.
2026-05-22
Funding Concerns for Space Science Raised
Reports indicated a lack of new funding for instrument development and science investigations, raising concerns about the pace of future research efforts, including those related to astronaut health.
2026-08-10
Agencies Intensify SANS Research
NASA and the European Space Agency (ESA) are actively researching SANS, developing new devices and strategies to prevent vision loss in astronauts for future deep-space missions.
Frequently Asked Questions
SANS is a condition that causes vision degradation and structural changes in astronauts' eyes during spaceflight. It is primarily caused by fluid shifts in microgravity, which increase pressure in the skull and around the eyes, leading to symptoms like blurred vision and farsightedness.
Discussion
Be the first to share your thoughts.